Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More time to buy more before the PR! eom
As a result of this, the parties have decided to rewrite the press release. They require their counsel to approve the new draft, so $GVSI's PR may be delayed to Tuesday. Let's continue to be stupid.
As a result of this, the parties have decided to rewrite the press release. They require their counsel to approve the new draft, so $GVSI's PR may be delayed to Tuesday. Let's continue to be stupid. https://t.co/NAiNg59Q3L
— George Sharp - Advocate for truth in the OTC (@GeorgeASharp) February 4, 2024
$IGPK - The dots on this one seems to line up very well. Good job to everyone who contributed to the research. If it's true, this will be a very exciting play. I'm in!
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) January 26, 2024
Best of luck! https://t.co/uxslXSbp54
Gaurav Chandra M.D.
@drgauravchandra
Our collaboration is dedicated to finding practical solutions for the long-standing problem of how to live longer and better. By 2030, the number of people aged 65 and over will exceed one billion, so we need to shift our traditional approaches to medicine towards a more proactive strategy focusing on prevention and patient participation while firmly rooted in the science of aging.
To achieve this, we are incorporating a Software as a Service (SaaS) solution that uses multi-omic testing and AI algorithms to identify early signs of organ distress, allowing for timely interventions and improving therapeutic outcomes.
Our precision medicine suite incorporates patient profiling, proteomics, genomics, and AI to enhance lifespan and, more importantly, healthspan.
The new Enzolytics AI platform offers real-world data analytics capabilities to discover novel biomarkers and targets and to stratify patient cohorts for research purposes.
We are excited to be taking bold new steps in exciting directions, expanding our horizons as we work towards achieving our goal.
@ZainKhalpey
#ENZC #LONGEVITY #AI https://finance.yahoo.com/news/enzolytics-inc-announces-partnership-khalpey-130000160.html?.tsrc=rss
Our collaboration is dedicated to finding practical solutions for the long-standing problem of how to live longer and better. By 2030, the number of people aged 65 and over will exceed one billion, so we need to shift our traditional approaches to medicine towards a more…
— Gaurav Chandra M.D. (@drgauravchandra) January 16, 2024
Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Announces-Partnership-With-the-Khalpey-AI-Lab-To-Forge-the-Future-of-Multi-Organ-Remodeling-and-Rejuvenat?id=427270
1800? eom
Hey! Happy New year. I pretty new here, but I'm adding tomorrow, as well!
George Sharp - Advocate for truth in the OTC
@GeorgeASharp
Had a productive dinner meeting in Miami, a blockchain hotspot. Legitimate OTC issuers may have opportunities in 2024, as many of these companies are looking to leverage their development into equity funding. $FORW is looking to add blockchain to its portfolio. $GVSI $SRNW $WNFT
8:42 AM · Dec 29, 2023
·
2,857
Views
Had a productive dinner meeting in Miami, a blockchain hotspot. Legitimate OTC issuers may have opportunities in 2024, as many of these companies are looking to leverage their development into equity funding. $FORW is looking to add blockchain to its portfolio. $GVSI $SRNW $WNFT
— George Sharp - Advocate for truth in the OTC (@GeorgeASharp) December 29, 2023
Thanks Eliot! She's looking good! EOM
Hey longs! I joined the party,, yesterday. Sure glad I did. I've been passing the word on Twitter!
$SAGA has just filed a 10-Q!
Sagaliam Acquisition Corp (0001855351)
Date Filed: 2023-12-18 21:47:24 EST
Filing URL: https://sec.gov/Archives/edgar/data/1855351/000149315223045332/0001493152-23-045332-index.htm
$SAGA has just filed a 10-Q!
— SpacRight (@SpacRight) December 19, 2023
Sagaliam Acquisition Corp (0001855351)
Date Filed: 2023-12-18 21:47:24 EST
Filing URL: https://t.co/s5R0JxW2C7
You're welcome. Eom
$ENZC $SAGA The GLD motion for preliminary injunction hearing resulted in an order that is very similar to the prior restraining order except the vote can happen 45 days after SAGA files an amended proxy statement that cures any misrepresentations or omissions per the SEC. So basically the order keeps the status quo and the potential vote alive and gives SAGA 15 more days once that condition precedent is met. No other determinations were made nor issues addressed. See order attached hereto.
$ENZC $SAGA The GLD motion for preliminary injunction hearing resulted in an order that is very similar to the prior restraining order except the vote can happen 45 days after SAGA files an amended proxy statement that cures any misrepresentations or omissions per the SEC. So… pic.twitter.com/tTqTU2duhS
— King of Prussia (@ImKingofPrussia) December 12, 2023
Dr. Chandra to ENZC Shareholders: We empathize with the pain our shareholders feel and are fully committed to exceeding their expectations. We are confident in our ability to create value and will continue to work tirelessly towards achieving our goals.
We empathize with the pain our shareholders feel and are fully committed to exceeding their expectations. We are confident in our ability to create value and will continue to work tirelessly towards achieving our goals.
— Gaurav Chandra M.D. (@drgauravchandra) December 12, 2023
New Doc Chandra Twitter post:
It's worth remembering that the heaviest rains come from the darkest clouds. This reminds us that there is always hope, even in our darkest moments. We must have faith that this shall pass and emerge from it STRONGER and more vital than ever BEFORE. #ENZCstrong #assetbuiding
— Gaurav Chandra M.D. (@drgauravchandra) December 12, 2023
Dr. Chandra Twitter post:
The human microbiome (HMB) is a vital part of our overall health and well-being, even though it is often overlooked. The microorganisms present in the HMB produce metabolites that are believed to be the root cause of many diseases. However, this discovery can lead to the…
— Gaurav Chandra M.D. (@drgauravchandra) December 11, 2023
I think I'm going to get some green candlesticks for Christmas. :)
yep!
$ENZC $SAGA Just doing some reading. Found both of these in SAGA's SEC Edgar filings.
$ENZC $SAGA Just doing some reading. Found both of these in SAGA's SEC Edgar filings. pic.twitter.com/nkqyQgl1wZ
— King of Prussia (@ImKingofPrussia) November 21, 2023
$ENZC 💱 DIVIDEND 💱
$ENZC 💱 DIVIDEND 💱
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) November 20, 2023
Many are speculating what the dividend ratio will be. First thing to point out is that this is NOT the official ratio. That will be disclosed when the filings are complete. They explicitly say its "subject to change" and is only an estimate. They also… https://t.co/WlGwyqQXoZ pic.twitter.com/KLN83eVmvV
Q3 report!
$ENZC 🗞Q3 Report🗞
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) November 20, 2023
There was a big disclosure in the filing;
1️⃣ "𝘚𝘪𝘯𝘤𝘦 𝘵𝘩𝘦 𝘴𝘢𝘭𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘰𝘱𝘦𝘳𝘢𝘵𝘪𝘯𝘨 𝘴𝘶𝘣𝘴𝘪𝘥𝘪𝘢𝘳𝘪𝘦𝘴 𝘝𝘪𝘳𝘰𝘨𝘦𝘯𝘵𝘪𝘤𝘴, 𝘐𝘯𝘤..."
This implies the sale is done.🔥🔥🔥
2️⃣ "𝘛𝘩𝘦 𝘤𝘰𝘮𝘱𝘢𝘯𝘺 𝘩𝘢𝘴 𝘷𝘰𝘵𝘦𝘥 𝘪𝘵𝘴… https://t.co/rG6gWC8Ono pic.twitter.com/sTHOsFhJH2
New Dr. Chandra Twitter post: Greatness comes with effort, dedication, and perseverance. Such is the case with biologics. It calls for pushing past our limits, stepping out of our comfort zones, and learning from our decades of experience. Thanks to AI, we have been incredibly empowered. Our size is insignificant, as the power of our science, resolve, and drive to make a positive impact sets us apart. We have grown and evolved throughout this journey and will achieve exceptional outcomes.
Greatness comes with effort, dedication, and perseverance. Such is the case with biologics. It calls for pushing past our limits, stepping out of our comfort zones, and learning from our decades of experience. Thanks to AI, we have been incredibly empowered. Our size is…
— Gaurav Chandra M.D. (@drgauravchandra) November 10, 2023
New Dr. Chandra post!
Yes, we continue to advance on the planned milestones. The required steps for SPAC are in process and an update on partnerships and progress shall be provided through an official press release and filings in due course. We appreciate your continued faith and patience. #ENZC
— Gaurav Chandra M.D. (@drgauravchandra) November 7, 2023
Great post archilles. Eom.
To lose patience is to lose the battle.
Own ENZC for your dividend. eom
$SAGA SS Updated. They now have a Market Cap of $548MM.
$SAGA SS Updated. They now have a Market Cap of $548MM.
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) October 25, 2023
Imagine a $87MM OTC company owning 91% of a $548MM company.
IYKYK - see you at the top 💎$ENZC 🏆 https://t.co/8Cawnf1scf pic.twitter.com/7AXx4292OR
NASDAQ or bust! Onward and upward! eom
Tender Offer Notification 🔔
$SAGA shareholders just received a Tender Offer Notification. This allows you to elect your shares for redemption by November 15th. Per the SEC, a #SPAC does not need public approval if they are going to have all the votes (>65%).
🔔Tender Offer Notification 🔔$SAGA shareholders just received a Tender Offer Notification. This allows you to elect your shares for redemption by November 15th. Per the SEC, a #SPAC does not need public approval if they are going to have all the votes (>65%). $ENZC 🏆 pic.twitter.com/bumJuZtwTV
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) October 25, 2023
Looks like they may need to put some clothes on. LOL Closed up 10% or so.
Up! Very large transactions. eom
Diamond hands here as well!
$SAGA board has fixed the close of business on October 17, 2023, as the "Record Date" for determing stockholders entitled to receive notice of and vote at the special meeting.
🗳 VOTING 🗳$SAGA board has fixed the close of business on October 17, 2023, as the "Record Date" for determing stockholders entitled to receive notice of and vote at the special meeting.
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) October 16, 2023
⚠️ Tomorrow $ENZC pic.twitter.com/tcJkeYHxbd
We knew about Clone-3 for #HIV, but now for the 1st🥇time, we’re hearing about ??????????-?? for HIV, and ??????????-?????? ?????? ??????????-?????? for #SARSCoV2 🤯🤯🤯
#BGEN #ENZC 🔥🔥🔥
— 𝓓𝓮𝓶𝓲 ᥫ᭡ (@Demi6851) September 29, 2023
We knew about Clone-3 for #HIV, but now for the 1st🥇time, we’re hearing about 𝗖𝗹𝗼𝗻𝗲-𝟳 for HIV, and 𝗛𝘂𝗺𝗮𝗻-𝟭𝟵𝗚 𝗮𝗻𝗱 𝗛𝘂𝗺𝗮𝗻-𝟭𝟵𝗔 for #SARSCoV2 🤯🤯🤯
HIV
“Biogenysis is pursuing a comprehensive solution for both preventing and curing… pic.twitter.com/84enwy8HuZ
Yes, I've been going through the new website. It does look impressive!
We are launching the website http://biogenysis.com #BGEN #ENZC
https://twitter.com/drgauravchandra/status/1707744981400621452
For those ripping on Barry at $SAGA, you have no clue how this works. He is like the executor of the SPAC. Once de-SPAC occurs, the new executive team comes in. Per Exhibit 6:
✅
@drgauravchandra
will be CEO
✅ C. Cotropia will be COO
✅ J. Cotropia and Harry will be CSO.
For those ripping on Barry at $SAGA, you have no clue how this works. He is like the executor of the SPAC. Once de-SPAC occurs, the new executive team comes in. Per Exhibit 6:
— Zach (@CryptoGodDude) September 22, 2023
✅ @drgauravchandra will be CEO
✅ C. Cotropia will be COO
✅ J. Cotropia and Harry will be CSO.$ENZC pic.twitter.com/5A3Y8zj57P
Dr. Chandra Tweet: #BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to revolutionize the fight against #HIV , #COVID19 mutations, and other viruses. Collaborating with pharmaceutical companies, our focus is to cover all viruses in our repository, providing patients with necessary diagnostics and therapies. Our "AI Platform is constantly evolving with disruptive innovations" in healthcare. We are proud to be at the forefront of this crucial work and look forward to continuing to positively impact the world. #ENZC #NASDAQ https://nasdaq.com/press-release/enzolytics-announces-the-signing-of-the-business-combination-agreement-with-sagaliam
Last edited
4:37 PM · Sep 18, 2023
·
3,407
Views
#BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to…
— Gaurav Chandra M.D. (@drgauravchandra) September 18, 2023
Looking forward to Monday! eom
NASDAQ trending on Twitter with ENZC all over it! Great day to be an ENZC investor!